Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 31, 2025	Oct. 31, 2024	Oct. 31, 2025	Oct. 31, 2024
Income Statement [Abstract]
Net sales	$ 70,096	$ 47,764	$ 141,200	$ 96,157
Cost of products sold	50,376	33,812	100,550	69,717
Gross profit	19,720	13,952	40,650	26,440
Operating expenses	15,613	9,518	31,733	19,431
Operating profit	4,107	4,434	8,917	7,009
Other income (expense), net	407	(61)	575	266
Interest expense	(1,061)	(442)	(2,119)	(914)
Profit before income taxes	3,453	3,931	7,373	6,361
Income tax expense	915	916	1,676	1,108
Net earnings	2,538	3,015	5,697	5,253
Less: Net earnings attributable to the non-controlling interest	93	7	159	52
Net earnings attributable to Kewaunee Scientific Corporation	$ 2,445	$ 3,008	$ 5,538	$ 5,201
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders
Basic (in dollars per share)	$ 0.85	$ 1.05	$ 1.94	$ 1.82
Diluted (in dollars per share)	$ 0.82	$ 1.01	$ 1.86	$ 1.75
Weighted average number of common shares outstanding
Basic (in shares)	2,866	2,872	2,859	2,861
Diluted (in shares)	2,990	2,974	2,977	2,971